These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 5843584

  • 1. [Proketazine in the treatment of schizophrenia].
    Jakubik A, Aleksandrowicz J.
    Neurol Neurochir Psychiatr Pol; 1965; 15(4):639-45. PubMed ID: 5843584
    [No Abstract] [Full Text] [Related]

  • 2. [Proketazine in the treatment of psychotic syndromes].
    Klosińska B, Wierzbicki T.
    Psychiatr Pol; 1967; 1(1):69-71. PubMed ID: 5597274
    [No Abstract] [Full Text] [Related]

  • 3. Excessive mortality in schizophrenic patients on chronic phenothiazines treatment.
    Matsuki A, Oyama T, Izai S, Zsigmond EK.
    Agressologie; 1972; 13(6):407-18. PubMed ID: 4652242
    [No Abstract] [Full Text] [Related]

  • 4. An uncontrolled clinical study with piperacetazine in the maintenance treatment of chronic schizophrenic patients.
    Amin MM, Brahm E, Ban TA, Lehmann HE.
    Psychopharmacol Bull; 1977 Jul; 13(3):10-1. PubMed ID: 18753
    [No Abstract] [Full Text] [Related]

  • 5. Piperacetazine in ambulatory chronic schizophrenic patients.
    Rada RT, Donlon PT.
    Curr Ther Res Clin Exp; 1974 Feb; 16(2):124-9. PubMed ID: 4156665
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A standard-controlled clinical study with propericiazine in schizophrenic patients.
    Ananth JV, Ban TA.
    Psychopharmacol Bull; 1977 Jul; 13(3):19-20. PubMed ID: 18754
    [No Abstract] [Full Text] [Related]

  • 8. ["Depressive shift" in the course of treatment of schizophrenic psychosis with phenothiazines].
    Bohacek N.
    Neuropsihijatrija; 1967 Jul; 15(1):97-103. PubMed ID: 5191808
    [No Abstract] [Full Text] [Related]

  • 9. [Comparative study of 2 drugs and a placebo in chronic schizophrenia].
    Tetreault L.
    Actual Pharmacol (Paris); 1969 Jul; 22():1-18. PubMed ID: 4927120
    [No Abstract] [Full Text] [Related]

  • 10. [Clinico-neuroleptic studies of the neuroleptic agent Propericiazine with special consideration of the neuroleptic threshold].
    Haase HJ, Deinzer C, Rhinow E.
    Med Welt; 1968 Jul 06; 27():1580-4. PubMed ID: 4388432
    [No Abstract] [Full Text] [Related]

  • 11. A controlled study of mesoridazine: an effective treatment for schizophrenia.
    McIndoo MV.
    South Med J; 1971 May 06; 64(5):592-6. PubMed ID: 4929612
    [No Abstract] [Full Text] [Related]

  • 12. Clinical evaluation of butaperazine.
    Feldman PE.
    Psychosomatics; 1967 May 06; 8(1):26-8. PubMed ID: 4382889
    [No Abstract] [Full Text] [Related]

  • 13. [Principles of a differentiated treatment of schizophrenia using psychotropic agents].
    Awruzkij GJ.
    Psychiatr Neurol Med Psychol (Leipz); 1966 Dec 06; 18(12):459-61. PubMed ID: 5983906
    [No Abstract] [Full Text] [Related]

  • 14. Letter: Sudden death while on phenothiazines.
    Bland RC.
    Can Psychiatr Assoc J; 1975 Jun 06; 20(4):323-4. PubMed ID: 1182645
    [No Abstract] [Full Text] [Related]

  • 15. [Clinical remarks on the therapeutic activity of propericiazine].
    Nava V.
    G Psichiatr Neuropatol; 1967 Jun 06; 95(1):127-51. PubMed ID: 4386098
    [No Abstract] [Full Text] [Related]

  • 16. [Pipothiazine (piportil) in the treatment of various forms of schizophrenia].
    Matkowski K, Sep-Kowalikowa B.
    Psychiatr Pol; 1979 Jun 06; 13(4):421-3. PubMed ID: 42095
    [No Abstract] [Full Text] [Related]

  • 17. [Clinical experiences with thiothixene (navane) in chronic schizophrenia].
    Gann G.
    Wien Med Wochenschr; 1968 Jan 06; 118(1):10-3. PubMed ID: 5668801
    [No Abstract] [Full Text] [Related]

  • 18. [Effects of TPN-12 Sandoz in schizophrenia].
    Pogorzelski W, Rogiewicz A, Wojdyslawska I.
    Psychiatr Pol; 1973 Jan 06; 7(1):65-8. PubMed ID: 4715834
    [No Abstract] [Full Text] [Related]

  • 19. [Liver enzyme activity in patients with schizophrenia in the course of treatment with majeptil].
    Danilenko ET, Vlokh II.
    Vrach Delo; 1976 Aug 06; (8):111-4. PubMed ID: 14445
    [No Abstract] [Full Text] [Related]

  • 20. An evaluation of the permanence of the "tardive dyskinesias".
    Paulson GW.
    Dis Nerv Syst; 1968 Oct 06; 29(10):692-4. PubMed ID: 5717285
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.